DK1556021T3 - Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger - Google Patents

Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger

Info

Publication number
DK1556021T3
DK1556021T3 DK03809247T DK03809247T DK1556021T3 DK 1556021 T3 DK1556021 T3 DK 1556021T3 DK 03809247 T DK03809247 T DK 03809247T DK 03809247 T DK03809247 T DK 03809247T DK 1556021 T3 DK1556021 T3 DK 1556021T3
Authority
DK
Denmark
Prior art keywords
compositions
flavonoids
treatment
menthol
methods
Prior art date
Application number
DK03809247T
Other languages
English (en)
Inventor
Kurt Frimann Berg
Original Assignee
Immupharm As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immupharm As filed Critical Immupharm As
Application granted granted Critical
Publication of DK1556021T3 publication Critical patent/DK1556021T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03809247T 2002-10-24 2003-09-19 Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger DK1556021T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200201614 2002-10-24
PCT/DK2003/000608 WO2004037237A1 (en) 2002-10-24 2003-09-19 Pharmaceutical compositions comprising flavonoids and menthol

Publications (1)

Publication Number Publication Date
DK1556021T3 true DK1556021T3 (da) 2008-04-28

Family

ID=32116193

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03809247T DK1556021T3 (da) 2002-10-24 2003-09-19 Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger

Country Status (11)

Country Link
US (2) US7585890B2 (da)
EP (1) EP1556021B1 (da)
CN (1) CN1717227A (da)
AT (1) ATE381323T1 (da)
AU (1) AU2003263162B2 (da)
CA (1) CA2511431A1 (da)
DE (1) DE60318237T2 (da)
DK (1) DK1556021T3 (da)
ES (1) ES2298618T3 (da)
PL (1) PL375621A1 (da)
WO (1) WO2004037237A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
NZ560633A (en) * 2005-03-11 2011-08-26 Neuprotect Pty Ltd Flavonoid compounds and uses thereof
FR2901706A1 (fr) * 2006-06-01 2007-12-07 Persee Medica Soc Par Actions Compositions nasale et buccale pour lutter contre le ronflement
FR2901705A1 (fr) * 2006-06-01 2007-12-07 Persee Medica Soc Par Actions Composition pour lutter contre le ronflement se presentant sous la forme d'un spray nasal
WO2008106979A2 (en) * 2007-03-02 2008-09-12 Immupharm A/S Pharmaceutical compositions comprising flavonoids and xylitol
JP5579449B2 (ja) 2008-02-01 2014-08-27 株式会社プロテクティア 膜融合阻害剤
DE102009044974A1 (de) * 2009-07-23 2011-01-27 Henkel Ag & Co. Kgaa Verwendung von Dihydroquercetin und mindestens einer Aminosäure zur positiven Beeinflussung des natürlichen Pigmentierungsprozesses
CN102480952B (zh) * 2009-07-31 2015-01-21 国立大学法人大阪大学 抗菌剂
WO2012031123A2 (en) 2010-09-01 2012-03-08 Trythisfirst, Inc. Method of treating ear infections
US12016950B2 (en) 2010-09-01 2024-06-25 Try This First, Inc. Devices and methods for treating ear pain
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
TR201808978T4 (tr) 2011-02-11 2018-07-23 Zx Pharma Llc Çok partiküllü l-mentol formülasyonları ve ilgili yöntemler.
CN103813726B (zh) 2011-09-09 2018-01-05 菲利普莫里斯生产公司 包含香味递送材料的吸烟制品
CN102343083A (zh) * 2011-10-17 2012-02-08 中国科学院成都生物研究所 一种抗病毒的组合药物
EP2641904A1 (en) * 2012-03-23 2013-09-25 Twincore Zentrum für Experimentelle und Klinische Infektionsforschung GmbH Flavone derivatives and their use
KR101426996B1 (ko) 2012-07-24 2014-08-05 가톨릭대학교 산학협력단 테트라케라 스캔덴스 에탄올 추출물을 유효성분으로 포함하는 항바이러스 조성물 및 이의 용도
CN103156831A (zh) * 2013-03-28 2013-06-19 南京中医药大学 一种荆芥活性成分组合物及其在医药上的应用
EP2988824B1 (en) 2013-04-23 2018-11-07 Zx Pharma, Llc Enteric coated multiparticulate composition with proteinaceous subcoat
US9034401B1 (en) 2014-01-23 2015-05-19 Matrixx Initiatives, Inc. Pharmaceutical compositions comprising plant extracts and methods for reducing duration of a common cold using same
US20150231112A1 (en) * 2014-02-14 2015-08-20 Brian Stanislaws Paul Nasal and sinus wash compositions and methods
CA2973217A1 (en) 2015-02-11 2016-08-18 The Fix, Llc Compositions and methods for combination ingredient delivery
US20190358196A1 (en) * 2016-07-27 2019-11-28 Henry C. Lowe Pi 4-kinase inhibitor as a therapeutic for viral hepatitis, cancer, malaria. autoimmune disorders and inflammation, and a radiosensitizer and immunosuppressant
CN106265630A (zh) * 2016-10-13 2017-01-04 吉林大学 穗花杉双黄酮在研发治疗肺炎药物中的应用
FR3057773B1 (fr) * 2016-10-21 2020-06-19 Universite Claude Bernard Lyon 1 Nouvelles compositions antivirales pour le traitement des infections liees aux coronavirus
CN106963754B (zh) * 2017-02-17 2021-05-04 深圳市太空科技南方研究院 木犀草素及其类似物用于调节生物节律的用途
US10639294B2 (en) 2018-10-02 2020-05-05 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite
US11304968B2 (en) 2018-11-16 2022-04-19 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide
PH12021551857A1 (en) * 2019-02-08 2022-07-25 Ind Ta‰Cnica Pecuaria S A Antioxidant composition comprising quercetagetin and gallic acid
PL3980031T3 (pl) * 2019-06-10 2026-04-20 Firebrick Pharma Limited Zapobieganie zakażeniom wysoce patogennymi wirusami poprzez miejscowe stosowanie jodopowidonu na błony śluzowe
JP7758353B2 (ja) * 2020-03-23 2025-10-22 クザップ リサーチ アンド デベロップメント エルエルシー 経口テルペンシクロデキストリン包接体ビヒクル
CA3184651A1 (en) * 2020-05-29 2021-12-02 Vedicinals India Private Limited A composition for management of covid-19 and associated disorders
US20240009177A1 (en) 2020-09-21 2024-01-11 Ramot At Tel-Aviv University Ltd. Combination compositions having anti-viral activities and uses thereof
WO2023133412A2 (en) * 2022-01-05 2023-07-13 Prophase Labs, Inc. Compositions having synergistic anti-viral action and methods for treating coronavirus

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4523589A (en) 1983-06-29 1985-06-18 Krauser Robert S Method and apparatus for treating ailments
US4889941A (en) * 1987-04-23 1989-12-26 Fisons Corporation Synthetic flavonoids as inhibitors of leukotrienes and 5-lipoxygenase
JPH0259513A (ja) 1988-08-24 1990-02-28 Kiyuukiyuu Yakuhin Kogyo Kk 口腔粘膜貼付型口臭防止剤
FR2726469B1 (fr) * 1994-11-08 1996-12-13 Adir Composition pharmaceutique pour l'administration orale de flavonoides
DE19504832A1 (de) 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
JP4135816B2 (ja) 1995-11-24 2008-08-20 株式会社林原生物化学研究所 水溶性を向上させたプロポリス抽出物
US5846557A (en) * 1996-03-20 1998-12-08 Cumberland Packing Corporation Chewing gum containing cough suppressing agent
KR20010013377A (ko) 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6224872B1 (en) * 1997-07-31 2001-05-01 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Composition
JPH11302184A (ja) * 1998-04-21 1999-11-02 Taisho Pharmaceut Co Ltd 点鼻用組成物
JP3763075B2 (ja) 1998-04-24 2006-04-05 サンスター株式会社 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物
AU2182400A (en) * 1998-12-21 2000-07-12 Biovail International Ltd. Soft and chewy cough and cold relief composition
US6063383A (en) 1999-01-28 2000-05-16 Hsu; Wu-Ching Pharmaceutical suppository composites for fever and influenza and method of producing the composites
ES2239010T3 (es) 1999-06-03 2005-09-16 JOHNSON & JOHNSON CONSUMER FRANCE SAS Extractos de chrysanthemum matricaire (tanacetum parthenium) utilizados contra los trastornos inflamatorios.
JP2003504327A (ja) 1999-07-08 2003-02-04 プレンダーガスト、パトリック、ティ． 感染症の治療を目的としたフラボン類、クマリン類および関連化合物の使用
FI20000004A0 (fi) 2000-01-03 2000-01-03 Slk Foundation Flavonoidilääke...
RS49778B (sr) * 2000-06-15 2008-06-05 Ad. "Zdravlje" Farmaceutsko-Hemijska Industrija, FARMACEUTSKI DEZINFEKCIONI PREPARAT NA BAZI Na-USNINATA I LEKOVITOG BILJA I POSTUPAK ZA NJIHOVO DOBIJANJE
CN1280836A (zh) * 2000-07-13 2001-01-24 贵阳高新顺业生物科技有限公司 玫瑰含片及制作方法
JP2002030000A (ja) * 2000-07-17 2002-01-29 Saburo Yasuda 風邪根本治療法
EP1307189B1 (en) * 2000-07-28 2006-05-10 Immupharm APS Use of hydroxyethylrutosides for treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
US6985719B2 (en) * 2000-12-21 2006-01-10 Nokia, Inc. Secure wireless backup mechanism
JP2002291441A (ja) 2001-03-30 2002-10-08 Sunstar Inc アストラガリン含有食品
JP2002363006A (ja) 2001-06-05 2002-12-18 Nippon Eisei Center:Kk 防腐防虫剤組成物
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
US6592896B2 (en) 2001-08-06 2003-07-15 The Quigley Corporation Medicinal composition and method of using it
US6579543B1 (en) 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin

Also Published As

Publication number Publication date
ATE381323T1 (de) 2008-01-15
CA2511431A1 (en) 2004-05-06
PL375621A1 (pl) 2005-12-12
US7585890B2 (en) 2009-09-08
DE60318237D1 (de) 2008-01-31
EP1556021B1 (en) 2007-12-19
WO2004037237A1 (en) 2004-05-06
US20060148726A1 (en) 2006-07-06
AU2003263162A1 (en) 2004-05-13
CN1717227A (zh) 2006-01-04
EP1556021A1 (en) 2005-07-27
AU2003263162B2 (en) 2009-05-07
US7671086B2 (en) 2010-03-02
US20090227670A1 (en) 2009-09-10
DE60318237T2 (de) 2008-12-18
ES2298618T3 (es) 2008-05-16

Similar Documents

Publication Publication Date Title
PL375621A1 (pl) Kompozycje farmaceutyczne zawierające flawonoidy i mentol
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DK1458360T3 (da) Pulmonær afgivelse af aminoglycosider
DK1594833T3 (da) 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme
FR16C0028I1 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
NO20034056D0 (no) Proliferative sykdommer
TW200510416A (en) P38 inhibitors and methods of use thereof
ECSP045191A (es) "nuevos péptidos como inhibidores de la proteasa serina ns3 del virus de la hepatitis c"
ATE464303T1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
MY144616A (en) Substituted dihydroquinazolines
PA8583601A1 (es) Derivados de pirrolidona como inhibidores de maob
TW200618817A (en) Diffractive colorants for cosmetics
DK1414473T3 (da) Orale sammensætninger til behandling af hovedbundssygdomme
ATE486634T1 (de) Caspase 3, 8, 9 oder 10 inhibitoren in kombination mit mek inhibitoren zur behandlung von influenza
ATE422201T1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
ATE458750T1 (de) Antivirale mittel zur behandlung, kontrolle und prävention von infektionen durch coronaviren
BR0111785A (pt) Composições e métodos para tratamento de candidìase
NO20060420L (no) 2-aminobenzoylderivater
BRPI0411168A (pt) composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos
BRPI0410967A (pt) compostos, composições e seus usos para o tratamento de infecções por vìrus da famìlia flaviviridae
DK1523985T3 (da) Ikke-radioaktivt strontiumholdigt middel til behandling af kræft